Velano Vascular Gains CE Mark for Blood Draw Technology
Velano Vascular has snagged CE Mark certification for its blood-draw technology, the devicemaker announced Monday.
The product is meant to be an alternative to conventional blood drawing in hospitals, a process that relies on needle sticks and can require the use of more than one for successful blood specimen collection.
Instead, the device uses a peripheral intravenous catheter, which most hospitalized patients already have in place, to gather blood, the company says. The innovation is expected to improve patient experience and medical professional safety.
The devicemaker has begun clinical trials in the U.S. where the product was FDA 510(k) cleared in February. In addition, the company is collaborating with Brigham and Women’s Hospital in Boston, Mass.
Velano Vascular is based in Philadelphia, Pa., and San Francisco, Calif. — Jason Scott